NSE:GLAXO Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 9.49B INR in the quarter ending December 31, 2024, with 17.90% growth. This brings the company's revenue in the last twelve months to 37.05B, up 11.88% year-over-year. In the fiscal year ending March 31, 2024, GlaxoSmithKline Pharmaceuticals had annual revenue of 34.54B with 6.21% growth.

Revenue (ttm)

37.05B

Revenue Growth

+11.88%

P/S Ratio

n/a

Revenue / Employee

11.54M

Employees

3,211

Market Cap

425.01B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%
Mar 31, 2021	29.26B	-2.99B	-9.27%
Mar 31, 2020	32.24B	962.62M	3.08%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	516.03B
Divi's Laboratories	90.78B
Cipla	267.20B
Mankind Pharma	116.41B
Apollo Hospitals Enterprise	211.46B
Zydus Lifesciences	222.47B
Aurobindo Pharma	309.22B
Alkem Laboratories	127.57B

Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

6 days ago - GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ... - GuruFocus
6 days ago - Q3 2025 GlaxoSmithKline Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
3 months ago - GSK Pharma sets record date for Rs 12 special interim dividend on November 7, 2024 - Business Upturn

More News